Combination of mangiferin and T0901317 targeting autophagy promotes cholesterol efflux from macrophage foam cell in atherosclerosis

Qian Chen,Sijian Wang,Ruixia Bao,Dan Wang,Yuzheng Wu,Yi Zhang,Mengyang Liu,Tao Wang
DOI: https://doi.org/10.1186/s13020-023-00876-9
IF: 4.546
2024-01-08
Chinese Medicine
Abstract:The synthetic liver X receptor ligand (LXR) T0901317 (T0) has been reported to attenuate atherosclerosis (AS) without hyperglyceridemia due to innovative drug combination or nano-sized drug delivery. Given the key roles of mangiferin (MGF) in lipid metabolism and atherogenesis, it is critical to investigate progression of atherosclerotic lesion after combined treatment of MGF and T0.
pharmacology & pharmacy,integrative & complementary medicine
What problem does this paper attempt to address?